United Health Products, Inc.SEC Filings
|
|
All SEC filings by United Health Products, Inc. (UEEC) — annual and quarterly reports, current reports, registrations, proxies and ownership forms, updated in real time.
Financials
| 10-Q | Quarterly report | View Diff | Aug 14, 2026 | |
| 10-Q | Quarterly report | View Diff | May 15, 2026 | |
| 10-K | Annual report | View Diff | Apr 15, 2026 | |
| NT 10-K | Notice of late annual filing | Mar 31, 2026 | ||
| 10-Q | Quarterly report | View Diff | Nov 14, 2025 | |
| 10-Q | Quarterly report | View Diff | Aug 14, 2025 | |
| 10-Q | Quarterly report | View Diff | May 5, 2025 | |
| 10-K | Annual report | View Diff | Mar 28, 2025 | |
| 10-Q | Quarterly report | View Diff | Nov 12, 2024 | |
| 10-Q | Quarterly report | View Diff | Aug 13, 2024 |
Events
| 8-K | United Health Products Establishes Collaboration to Conduct Clinical Study | Jul 10, 2026 | ||
| 8-K | Entry Into a Material Definitive Agreement | Dec 22, 2025 | ||
| 8-K | Departure of Directors or Certain Officers | Jun 16, 2025 | ||
| 8-K | United Health Products Announces Otcqb Uplisting and Fda Update | May 8, 2025 | ||
| 8-K | United Health Products Provides Update on Fda Pma Application | Nov 6, 2024 | ||
| 8-K | Entry Into a Material Definitive Agreement | Jun 25, 2024 | ||
| 8-K | United Health Products Provides Update on Fda Pma Application and Amendment to White Lion Agreement | Jan 31, 2023 | ||
| 8-K | United Health Products Announces Equity Financing Agreement and Provides Corporate Update | Sep 7, 2022 | ||
| 8-K | United Health Products Provides Update on Fda Review | Jul 19, 2022 | ||
| 8-K | United Health Products Announces Settlement of Sec Investigation | Jun 23, 2022 |
Registrations and Prospectuses
| 424B3 | Prospectus supplement | Aug 17, 2026 | ||
| 424B3 | Prospectus supplement | May 22, 2026 | ||
| 424B3 | Prospectus supplement | May 14, 2026 | ||
| POS AM | Prospectus update (post-effective amendment) | May 11, 2026 | ||
| S-1 | IPO registration | View Diff | Jan 15, 2026 | |
| 424B3 | Prospectus supplement | Aug 20, 2024 | ||
| 424B3 | Prospectus supplement | Aug 1, 2024 | ||
| S-1/A | IPO registration | View Diff | Jul 25, 2024 | |
| S-1/A | IPO registration | View Diff | Jul 22, 2024 | |
| S-1/A | IPO registration | View Diff | Jul 15, 2024 |
Proxies
| DEF 14A | Definitive proxy | Jul 8, 2015 | ||
| PRE 14A | Preliminary proxy | View Diff | Jun 22, 2015 | |
| PRE 14A | Preliminary proxy | Dec 23, 2014 | ||
| DEFA14C | Additional information | Jul 7, 2010 | ||
| DEF 14C | Information statement | Jul 7, 2010 | ||
| PRE 14C | Preliminary information | Jun 9, 2010 | ||
| DEF 14C | Information statement | Feb 5, 2010 | ||
| DEFA14C | Additional information | Nov 6, 2009 | ||
| DEF 14A | Definitive proxy | View Diff | Nov 2, 2009 | |
| DEF 14C | Information statement | Nov 2, 2009 |
Other
| EFFECT | Notice of effectiveness | May 15, 2026 | ||
| EFFECT | Notice of effectiveness | Feb 2, 2026 | ||
| EFFECT | Notice of effectiveness | Jul 30, 2024 | ||
| CORRESP | Correspondence with SEC | Jul 26, 2024 | ||
| UPLOAD | Letter from SEC | Jul 3, 2024 | ||
| EFFECT | Notice of effectiveness | Sep 20, 2022 | ||
| CORRESP | Correspondence with SEC | Sep 15, 2022 | ||
| UPLOAD | Letter from SEC | Sep 14, 2022 | ||
| EFFECT | Notice of effectiveness | Sep 30, 2021 | ||
| CORRESP | Correspondence with SEC | Sep 29, 2021 |
Ownership
| 4 | Brian David Thom | Apr 9, 2025 | ||
| 4 | Brian David Thom | Apr 2, 2025 | ||
| SC 13D | Wendy Beplate Irrevocable Trust Acquires Stake in United Health Products, Inc. | Dec 19, 2024 | ||
| SC 13D/A | United Health Products, Inc. | Dec 4, 2024 | ||
| 4 | Brian David Thom | May 17, 2023 | ||
| 144 | Notice of proposed sale of securities | May 10, 2023 | ||
| 4 | Brian David Thom | Apr 21, 2023 | ||
| 5 | Kristofer Heaton | Feb 3, 2023 | ||
| 4 | Brian David Thom | Jan 17, 2023 | ||
| 5 | Brian David Thom | Jan 17, 2023 |